Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study.

Luisa Guidi, Elisa Gremese, Antonio Gasbarrini, Alessandro Armuzzi, Daniela Pugliese, Alexandra Maura Berrino, Barbara Tolusso, Manuela Marzo, Carla Felice, Matteo Ruggeri, Laura Cantoro, Paola Balestrieri, Fortunata Civitelli, Lorenzo Bertani, Francesco Costa, Franca Viola, Michele Cicala, Anna Kohn

Risultato della ricerca: Contributo in rivistaArticolo in rivista

37 Citazioni (Scopus)

Fingerprint Entra nei temi di ricerca di 'Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study.'. Insieme formano una fingerprint unica.

Medicine & Life Sciences